Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Clinical trial NCT06665724 · COMPLETED

Trial details

NCT number: NCT06665724
Sponsor: Universität Münster
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anaplastic Astrocytoma (AA)Anaplastic Oligodendroglioma (AO)Glioblastoma (GBM)

Start date: 2025-01-27
Primary completion: 2026-02-09
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.